These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17715534)

  • 1. India: multi-national pharmaceutical company challenges patent law.
    Betteridge G
    HIV AIDS Policy Law Rev; 2007 May; 12(1):35, 38. PubMed ID: 17715534
    [No Abstract]   [Full Text] [Related]  

  • 2. India remains on US trade "priority watch list" for failing to uphold international drug company patents.
    Arie S
    BMJ; 2013 May; 346():f2949. PubMed ID: 23657189
    [No Abstract]   [Full Text] [Related]  

  • 3. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 4. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campaigners urge India to resist pressure to change patent laws.
    Kmietowicz Z
    BMJ; 2015 Jun; 350():h3218. PubMed ID: 26066656
    [No Abstract]   [Full Text] [Related]  

  • 6. Will the Modi government succumb to US and industry pressure to modify its pro-access pharmaceutical patent policy?
    Baker BK
    Expert Opin Ther Pat; 2015 Jun; 25(6):625-8. PubMed ID: 25704359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Court dismisses Novartis challenge to Indian patent law.
    Mudur G
    BMJ; 2007 Aug; 335(7614):273. PubMed ID: 17690349
    [No Abstract]   [Full Text] [Related]  

  • 8. International trade and Canadian patent law.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):47-53. PubMed ID: 11837027
    [No Abstract]   [Full Text] [Related]  

  • 9. Patent litigation in India continues to throw up new challenges.
    Reddy Thikkavarapu P
    Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 11. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G
    BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
    [No Abstract]   [Full Text] [Related]  

  • 13. Will the refusal of patent protection for Glivec® discourage future pharmaceutical innovation in India?
    Albutt J
    Pharm Pat Anal; 2013 Jul; 2(4):439-41. PubMed ID: 24237119
    [No Abstract]   [Full Text] [Related]  

  • 14. Indian generic drug production. Benefits of EU-India free trade agreement.
    Ager B
    BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277
    [No Abstract]   [Full Text] [Related]  

  • 15. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 16. The production of generic drugs in India.
    Love J
    BMJ; 2011 Mar; 342():d1694. PubMed ID: 21427048
    [No Abstract]   [Full Text] [Related]  

  • 17. Novartis challenges India's drug patent laws in Supreme Court.
    Billingsley M
    BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 19. Indian pharmaceutical patent prosecution: The changing role of Section 3(d).
    Sampat BN; Shadlen KC
    PLoS One; 2018; 13(4):e0194714. PubMed ID: 29608604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered in India--patent law 2.0.
    Castellani JJ
    N Engl J Med; 2013 Nov; 369(22):2163. PubMed ID: 24283241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.